Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 1/20 | 0.43 |
| ▸ | FGF2 | P09038 | 1/20 | 0.40 |
| ▸ | BDNF | P23560 | 3/20 | 0.37 |
| ▸ | PTN | P21246 | 2/20 | 0.37 |
| ▸ | MDK | P21741 | 2/20 | 0.37 |
| ▸ | IDUA | P35475 | 1/20 | 0.37 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.36 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.36 |
| ▸ | CCL2 | P13500 | 1/20 | 0.36 |
| ▸ | CCL5 | P13501 | 1/20 | 0.36 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | IGF2R | P11717 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27154937 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL31525197 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL29416055 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL14493679 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL14365903 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL14433730 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL29471730 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL18407321 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL21907252 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK | |
| SCHEMBL13589989 | 1.00 | FGF1 (0.43) | FGF1FGF2BDNFPTNMDK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200376011-A1 | COMPOSITION FOR TREATING CANCER INCLUDING ALGINATE OLIGOSACCHARIDE AS AN ACTIVE INGREDIENT | BIO3S, INC | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200376011-A1 | COMPOSITION FOR TREATING CANCER INCLUDING ALGINATE OLIGOSACCHARIDE AS AN ACTIVE INGREDIENT | ALG1, FUT5, FUT6 | FGF1 919/4885FGF2 1100/4885BDNF 4838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.